Johnson Matthey PLC (LON:JMAT - Get Free Report) shot up 30.4% during mid-day trading on Thursday . The stock traded as high as GBX 1,888 ($25.56) and last traded at GBX 1,811 ($24.52). 4,275,197 shares traded hands during trading, an increase of 55% from the average session volume of 2,752,536 shares. The stock had previously closed at GBX 1,389 ($18.80).
Johnson Matthey Price Performance
The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 62.73. The firm has a market cap of £2.89 billion, a price-to-earnings ratio of 29.40, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The company's 50-day moving average is GBX 1,307.66 and its 200-day moving average is GBX 1,376.55.
Johnson Matthey (LON:JMAT - Get Free Report) last posted its quarterly earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) earnings per share (EPS) for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. Equities research analysts predict that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.
Johnson Matthey Increases Dividend
The company also recently declared a dividend, which was paid on Wednesday, April 16th. Investors of record on Thursday, April 10th were given a dividend of GBX 32 ($0.43) per share. This is a positive change from Johnson Matthey's previous dividend of $22.00. The ex-dividend date of this dividend was Thursday, April 10th. This represents a dividend yield of 1.88%. Johnson Matthey's dividend payout ratio (DPR) is currently 130.84%.
Insider Buying and Selling at Johnson Matthey
In related news, insider Liam Condon bought 27 shares of the business's stock in a transaction on Wednesday, March 19th. The shares were purchased at an average price of GBX 1,445 ($19.56) per share, for a total transaction of £390.15 ($528.16). Insiders have purchased 75 shares of company stock worth $99,927 over the last quarter. Corporate insiders own 0.61% of the company's stock.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
See Also
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
